tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP

Compare Crispr Therapeutics AG (CRSP) vs. Competitors

10,891 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Crispr Therapeutics AG
$51.22
$4.92B
-8.11
49.50%
12 Buy
3 Hold
1 Sell
Moderate Buy
Intellia Therapeutics
$13.49
$1.59B
-2.54
99.26%
8 Buy
8 Hold
1 Sell
Moderate Buy
Apellis Pharmaceuticals
$40.79
$5.21B
-13.43
117.08%
3 Buy
16 Hold
0 Sell
Hold
Beam Therapeutics
$27.43
$2.68B
2.92
87.49%
11 Buy
1 Hold
0 Sell
Strong Buy
Legend Biotech
$18.20
$3.37B
-32.35
-41.94%
10 Buy
2 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$85.05
$6.94B
-18.86
279.69%
17 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CRSP
Crispr Therapeutics AG
51.22
11.92
30.33%
NTLA
Intellia Therapeutics
13.49
6.08
82.05%
APLS
Apellis Pharmaceuticals
40.79
21.37
110.04%
BEAM
Beam Therapeutics
27.43
11.96
77.31%
LEGN
Legend Biotech
18.16
-13.84
-43.25%
KYMR
Kymera Therapeutics
85.05
60.93
252.61%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts